![Michael Richard Dwyer Ashton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Richard Dwyer Ashton
Vorsitzender bei Komix Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Susan Ringdal | F | - | 19 Jahre | |
Nina Henderson | F | 73 | 8 Jahre | |
John Castellani | M | 73 | 8 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Gregory Todd Bosch | M | 61 | 8 Jahre | |
Charles Spicer | M | 59 | 6 Jahre | |
Samih Taleb Darwazah | M | 94 | 37 Jahre | |
Ronald L. Goode | M | 79 | 12 Jahre | |
Donald Clarke | M | 69 | 4 Jahre | |
Patrick Butler | M | 63 | 10 Jahre | |
Sandra N. Webb | M | 76 | 4 Jahre | |
Alister Hodges | M | - | 2 Jahre | |
Jim Walsh | M | 65 | 1 Jahre | |
Peter Larkin | M | 70 | 3 Jahre | |
David Kenneth Rowe-Ham | M | 89 | 9 Jahre | |
John D. Mills | M | 83 | 6 Jahre | |
Breffni Byrne | M | 78 | 11 Jahre | |
Robert Pickering | M | 64 | 9 Jahre | |
Stuart James | M | 74 | 4 Jahre | |
Pamela Kirby | M | 70 | 8 Jahre | |
Alex Martin Martin | M | 56 | 4 Jahre | |
Ayman Ahmed Sahli | M | 61 | 4 Jahre | |
Bryan Hotston | M | - | - | |
Jochen Gann | M | 60 | 4 Jahre | |
Brooke Clarke | F | - | 5 Jahre | |
Peter Speirs | M | 45 | 12 Jahre | |
Geoff Koontz | M | - | 9 Jahre | |
Jason Grenfell-Gardner | M | 49 | 4 Jahre | |
James W. Sharpe | M | - |
Astralis Ltd.
![]() Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | - |
Christopher Wightman | M | 66 | 14 Jahre | |
Manuel Tarabay | M | - |
Astralis Ltd.
![]() Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | - |
Kristen M. Kyriakou | F | - | 3 Jahre | |
Fabien Pictet | M | - |
Astralis Ltd.
![]() Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | 4 Jahre |
Steven M. Fulda | M | - |
Astralis Ltd.
![]() Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | 3 Jahre |
Danny Robert Hegglin | M | 62 | 4 Jahre | |
Michael Sapountzoglou | M | 63 | 7 Jahre | |
Samuel T. Barnett | M | - |
Astralis Ltd.
![]() Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | 3 Jahre |
Andrew Lancelot Vizard | M | 66 | 11 Jahre | |
Mihalis Sapountzoglou | M | 63 | 9 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigtes Königreich | 16 | 42,11% |
Vereinigte Staaten | 15 | 39,47% |
Australien | 7 | 18,42% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael Richard Dwyer Ashton
- Persönliches Netzwerk